Multifunctional core/shell nanoparticles cross-linked polyetherimide-folic acid as efficient notch-1 siRNA carrier for targeted killing of breast cancer

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Yang, Hong ^a   Li, Ying ^a   Li, Tingting ^a   Xu, Min ^a   Chen, Yin ^a   Wu, Chunhui ^a   Dang, Xitong ^b   Liu, Yiyao ^a  

^a UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; NANOSHELL; NOTCH1 PROTEIN, HUMAN; NOTCH1 RECEPTOR; POLYETHERIMIDE; POLYMER; SILICON DIOXIDE; SMALL INTERFERING RNA;

APOPTOSIS; BREAST NEOPLASMS; CELL PROLIFERATION; CHEMISTRY; DIAGNOSTIC USE; FEMALE; GENE THERAPY; GENE TRANSFER; GENETICS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOGRAPHY; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FOLIC ACID; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; MAGNETIC RESONANCE IMAGING; NANOSHELLS; POLYMERS; RECEPTOR, NOTCH1; RNA, SMALL INTERFERING; SILICON DIOXIDE;

EID: 84941653196     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07072     Document Type: Article

References (42)

1. Kim, S. H. et al. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J. Control. Release 129, 107-116 (2008).
2. Han, L. et al. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility. ACS Nano 6, 7340-7351 (2012).
3. Zhang, L. et al. Multifunctional fluorescent-magnetic polyethyleneimine functionalized Fe3O4-mesoporous silica yolk-shell nanocapsules for siRNA delivery. Chem. Commun (Camb). 48, 8706-8708 (2012).
4. Yang, H. et al. VCAM-1-targeted core/shell nanoparticles for selective adhesion and delivery to endothelial cells with lipopolysaccharide-induced inflammation under shear flow and cellular magnetic resonance imaging in vitro. Int. J. Nanomedicine 8, 1897-1906 (2013).
5. Lu, Y., Yin, Y., Mayers, B. T. & Xia, Y. Modifying the surface properties of superparamagnetic iron oxide nanoparticles through a sol2gel approach. Nano Lett 2, 183-186 (2002).
6. Graf, C., vossen, D. L. J., Imhof, A. & van Blaaderen, A. A general method to coat colloidal particles with silica. Langmuir 19, 6693-6700 (2003).
7. Xia, T. et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 3, 3273-3286 (2009).
8. Chen, Y. et al. Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer. Int. J. Nanomedicine 7, 359-368 (2012).
9. Sun, C., Sze, R. & Zhang, M. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. J. Biomed. Mater. Res. A. 78, 550-557 (2006).
10. Zhu, Y., Fang, Y. & Kaskel, S. Folate-conjugated Fe3O4@SiO2 hollow mesoporous spheres for targeted anticancer drug delivery. J. Phys. Chem. C. 114, 16382-16388 (2010).
11. Low, P. S., Henne, W. A. & Doorneweerd, D. D. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc. Chem. Res. 41, 120-129 (2008).
12. Pan, X. & Lee, R. J. Tumour-selective drug delivery via folate receptor-targeted liposomes. Expert Opin. Drug Deliv. 1, 7-17 (2004).
13. Sudimack, J. & Lee, R. J. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev. 41, 147-162 (2000).
14. Ridgway, J. et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444, 1083-1087 (2006).
15. Mamaeva, V. et al. Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer. Mol. Ther. 19, 1538-1546 (2011).
16. Zhang, G. et al. Fluorescent magnetic nanoprobes: design and application for cell imaging. J. Colloid. Interface. Sci. 351, 128-133 (2010).
17. Liu, Y. et al. Multifunctional nanoparticles of Fe(3)O(4)@SiO(2)(FITC)/PAH conjugated the recombinant plasmid of pIRSE2-EGFP/VEGF(165) with dual functions for gene delivery and cellular imaging. Expert Opin. Drug Deliv. 9, 1197-1207 (2012).
18. Shi, M. et al. Core/shell Fe3O4 @SiO2 nanoparticles modified with PAH as a vector for EGFP plasmid DNA delivery into HeLa cells. Macromol. Biosci. 11, 1563-1569 (2011).
19. Slowing, II, Wu, C. W., Vivero-Escoto, J. L. & Lin, V. S. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 5, 57-62 (2009).
20. Guo, L. et al.Hollow mesoporous carbon spheres-an excellent bilirubin adsorbent. Chem. Commun (Camb). 40, 6071-6073 (2009).
21. Shi, X. et al. Graphene-based magnetic plasmonic nanocomposite for dual bioimaging and photothermal therapy. Biomaterials 34, 4786-4793 (2013).
22. Meng, G., Liu, Y., Lou, C. & Yang, H. Emodin suppresses lipopolysaccharideinduced pro-inflammatory responses and NF-kappaB activation by disrupting lipid rafts in CD14-negative endothelial cells. Br. J. Pharmacol. 161, 1628-1644 (2010).
23. Zhao, F. et al. Roles for GP IIb/IIIa and alpha(v)beta(3) integrins inMDA-MB-231 cell invasion and shear flow-induced cancer cell mechanotransduction. Cancer Lett. 344, 62-73 (2014).
24. Li, L. et al. Notch-1 Signaling Promotes the Malignant Features of Human Breast Cancer through NF-kappaB Activation. PLoS One 9, e95912 (2014).
25. Meier, R. et al. Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133. Radiology 255, 527-535 (2010).
26. Cui, S. et al. In vivo targeted deep-tissue photodynamic therapy based on nearinfrared light triggered upconversion nanoconstruct. ACS Nano 7, 676-688 (2013).
27. Yang, H. et al. Investigation of folate-conjugated fluorescent silica nanoparticles for targeting delivery to folate receptor-positive tumors and their internalization mechanism. Int. J. Nanomedicine 6, 2023-2032 (2011).
28. Lawrier, G. A., Battersby, B. J.&Trau, M. Synthesis of optically complex core-shell colloidal suspensions: pathways to multiplexed biological screening. Adv Funct Mater 13, 887-896 (2003).
29. Lee, J. E. et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J. Am. Chem. Soc. 132, 552-557 (2010).
30. Zou, S. et al. Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin. Int. J. Nanomedicine 7, 3823-3835 (2012).
31. Zou, T. et al. Synthesis of poly(alpha, beta-[N-(2-hydroxyethyl)-L-aspartamide])- folate for drug delivery. J. Biomater. Sci. Polym. Ed. 21, 759-770 (2010).
32. Son, S. & Kim, W. J. Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery. Biomaterials 31, 133-143 (2010).
33. Liu, C. et al. The targeted co-delivery of DNA and doxorubicin to tumor cells via multifunctional PEI-PEG based nanoparticles. Biomaterials 34, 2547-2564 (2013).
34. Chen, G. et al. MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression. Biomaterials 30, 1962-1970 (2009).
35. Deng, L. et al. Development and optimization of doxorubicin loaded poly(lacticco- glycolic acid) nanobubbles for drug delivery into HeLa cells. J. Nanosci. Nanotechnol. 14, 2947-2954 (2014).
36. Liu, Y. et al. Silica nanoparticles as promising drug/gene delivery carriers and fluorescent nano-probes: recent advances. Curr. Cancer Drug Targets 11, 156-163 (2011).
37. Kano, A. et al. Grafting of poly(ethylene glycol) to poly-lysine augments its lifetime in blood circulation and accumulation in tumors without loss of the ability to associate with siRNA. J. Control. Release 149, 2-7 (2011).
38. Kumar, M. et al. Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells. Int. J. Nanomedicine 7, 3503-3516 (2012).
39. Kim, S. H. et al. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J. Control. Release 116, 123-129 (2006).
40. Miele, E. et al. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy. Int. J. Nanomedicine 7, 3637-3657 (2012).
41. Wu, F., Stutzman, A. & Mo, Y. Y. Notch signaling and its role in breast cancer. Front. Biosci. 12, 4370-4383 (2007).
42. Wang, Z. et al. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. J. Cell. Biochem. 109, 726-736 (2010).